Hasil Pencarian - Michael U. Callaghan

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease

    Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease oleh Alexander K. Glaros, Michael U. Callaghan, Wally R. Smith, Ahmar U. Zaidi

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3

    Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3 oleh Michael U. Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse‐Jarres, Víctor Jiménez‐Yuste, Midori Shima, Peter Trask, Christine L. Kempton, Craig M. Kessler, Gallia G. Levy, Flora Peyvandi

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

    Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial) oleh Ahmed A. Daak, Carlton D. Dampier, Beng Fuh, Julie Kanter, Ofelia A. Alvarez, L. Vandy Black, Melissa A. McNaull, Michael U. Callaghan, Alex George, Lynne Neumayr, Lee M. Hilliard, Fredrick Sancilio, Adrian L. Rabinowicz, Matthew M. Heeney

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: